Plain-English translation of NCT02823821 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This is a large, real-world study looking at whether the sodium concentration in dialysis fluid affects heart and blood vessel health. Dialysis centers will be randomly assigned to use one of two standard sodium levels in their dialysis machines, and researchers will track whether one level leads to better outcomes for patients over time.
People with end-stage kidney disease rely on dialysis to filter their blood, but the exact composition of the dialysis fluid may affect their risk of heart attacks and strokes. This study aims to find out whether adjusting the sodium level in dialysis fluid could reduce these serious complications.
You likely qualify if…
You likely don't qualify if…
Your dialysis center will be assigned to use one of two sodium levels in your regular dialysis treatments — you will not need to do anything different during your normal dialysis sessions. Researchers will track your health outcomes over approximately 2 to 5 years by reviewing your medical records, watching for heart-related events, and monitoring standard dialysis blood work that you already receive.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Australia